Theravance Biopharma, Inc.
Institutional Ownership & Holdings Analysis
About
theravance-biopharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Madison Avenue Partners, LP(2025-03-31) | $84.9M |
2 | Weiss Asset Management LP(2025-03-31) | $66.6M |
3 | Newtyn Management, LLC(2025-03-31) | $42.5M |
4 | BlackRock, Inc.(2025-03-31) | $30.8M |
5 | Irenic Capital Management LP(2025-03-31) | $24.7M |
6 | VANGUARD GROUP INC(2025-03-31) | $18.6M |
7 | Park West Asset Management LLC(2025-03-31) | $16.1M |
8 | Oasis Management Co Ltd.(2025-03-31) | $10.0M |
9 | STATE STREET CORP(2025-03-31) | $9.5M |
10 | Camber Capital Management LP(2025-03-31) | $8.9M |
11 | D. E. Shaw & Co., Inc.(2025-03-31) | $8.2M |
12 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $8.0M |
13 | DIMENSIONAL FUND ADVISORS LP(2025-03-31) | $5.8M |
14 | Nuveen Asset Management, LLC(2024-12-31) | $4.7M |
15 | BANK OF AMERICA CORP /DE/(2025-03-31) | $4.1M |
16 | CITADEL ADVISORS LLC(2025-03-31) | $3.9M |
17 | UBS Group AG(2025-03-31) | $3.7M |
18 | Nuveen, LLC(2025-03-31) | $3.3M |
19 | NORTHERN TRUST CORP(2025-03-31) | $3.1M |
20 | MORGAN STANLEY(2025-03-31) | $3.1M |
As of 2025-03-31
Value:$84.9M
As of 2025-03-31
Value:$66.6M
As of 2025-03-31
Value:$42.5M
As of 2025-03-31
Value:$30.8M
As of 2025-03-31
Value:$24.7M
As of 2025-03-31
Value:$18.6M
As of 2025-03-31
Value:$16.1M
As of 2025-03-31
Value:$10.0M
As of 2025-03-31
Value:$9.5M
As of 2025-03-31
Value:$8.9M
As of 2025-03-31
Value:$8.2M
As of 2025-03-31
Value:$8.0M
As of 2025-03-31
Value:$5.8M
As of 2024-12-31
Value:$4.7M
As of 2025-03-31
Value:$4.1M
As of 2025-03-31
Value:$3.9M
#17UBS Group AG
As of 2025-03-31
Value:$3.7M
#18Nuveen, LLC
As of 2025-03-31
Value:$3.3M
As of 2025-03-31
Value:$3.1M
As of 2025-03-31
Value:$3.1M
Total Institutional Holders:152
Top 10 Holders Own:76.4%